FDA Approves Beech Tree Labs’ Influenza IND Application

Beech Tree Labs, Inc., announced Thursday that the FDA has approved its IND for a 180 patient Phase 1/2a clinical evaluation of BTL-TML001, a novel therapeutic agent for treating acute influenza virus infections.
GEN